Yet another weight loss drug is now hard to get as high demand creates major shortages
Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk.Christopher Goodney/Bloomberg via Getty ImagesNovo Nordisk’s drug Saxenda is the latest to hit a shortage, as high demand for weight loss drugs sparks supply snags across the industry. Saxenda will have limited availability through the end of the year, according to a notice posted Tuesday on a
Read More